Tobias Akerstrom
Overview
Explore the profile of Tobias Akerstrom including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
361
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Klimacek B, Akerstrom T, Anneback M, Hellman P, Norlen O, Stalberg P
Langenbecks Arch Surg
. 2025 Mar;
410(1):90.
PMID: 40047926
Purpose: Small intestinal neuroendocrine tumours (SI-NETs) are the most common malignancy of the small bowel. Curative treatment is surgical, with exploratory laparotomy considered the standard approach. This study aimed to...
2.
Backman S, Botling J, Nord H, Ghosal S, Stalberg P, Juhlin C, et al.
J Pathol
. 2024 Oct;
264(4):357-370.
PMID: 39360347
Tumour evolution with acquisition of more aggressive disease characteristics is a hallmark of disseminated cancer. Metastatic pancreatic neuroendocrine tumours (PanNETs) in particular may progress from a low/intermediate to a high-grade...
3.
Xu K, Langenhuijsen J, Vietor C, Feelders R, van Ginhoven T, Elhassan Y, et al.
Eur J Endocrinol
. 2024 Aug;
191(3):345-353.
PMID: 39171965
Objective: Hereditary pheochromocytoma (hPCC) commonly develops bilaterally, causing adrenal insufficiency when standard treatment, radical adrenalectomy (RA), is performed. Partial adrenalectomy (PA) aims to preserve adrenal function, but with higher recurrence...
4.
Flynn A, Pattison A, Balachander S, Boehm E, Bowen B, Dwight T, et al.
Res Sq
. 2024 Jul;
PMID: 38978571
Hereditary -mutant pheochromocytomas (PC) and paragangliomas (PG) are rare tumours with a high propensity to metastasize although their clinical behaviour is unpredictable. To characterize the genomic landscape of these tumours...
5.
Backman S, Botling J, Nord H, Ghosal S, Stalberg P, Juhlin C, et al.
medRxiv
. 2024 Feb;
PMID: 38313278
Tumour evolution with acquisition of more aggressive disease characteristics is a hallmark of disseminated cancer. Metastatic pancreatic neuroendocrine tumours (PanNETs) in particular, show frequent progression from a low/intermediate to a...
6.
Zhang L, Akerstrom T, Mollazadegan K, Beuschlein F, Pacak K, Skogseid B, et al.
Endocr Relat Cancer
. 2023 Nov;
31(1).
PMID: 38031994
No abstract available.
7.
Zhang L, Akerstrom T, Mollazadegan K, Beuschlein F, Pacak K, Skogseid B, et al.
Endocr Relat Cancer
. 2023 May;
30(7).
PMID: 37185155
Core needle biopsy (CNB) has been used with caution in pheochromocytoma and paraganglioma (PPGL) due to concerns about catecholamine-related complications. While it is unclear what scientific evidence supports this claim,...
8.
Silins I, Sundin A, Lubberink M, OSullivan L, Gurnell M, Aigbirhio F, et al.
Eur J Nucl Med Mol Imaging
. 2022 Sep;
50(2):398-409.
PMID: 36074157
Purpose: [C]Metomidate positron emission tomography (PET) is currently used for staging of adrenocortical carcinoma and for lateralization in primary aldosteronism (PA). Due to the short half-life of carbon-11 and a...
9.
Mollazadegan K, Skogseid B, Botling J, Akerstrom T, Eriksson B, Welin S, et al.
Endocr Connect
. 2022 Feb;
11(3).
PMID: 35148276
Longitudinal changes in pancreatic neuroendocrine tumor (panNET) cell proliferation correlate with fast disease progression and poor prognosis. The optimal treatment strategy for secondary panNET grade (G)3 that has progressed from...
10.
Zhou J, Azizan E, Cabrera C, Fernandes-Rosa F, Boulkroun S, Argentesi G, et al.
Nat Genet
. 2021 Aug;
53(9):1360-1372.
PMID: 34385710
Most aldosterone-producing adenomas (APAs) have gain-of-function somatic mutations of ion channels or transporters. However, their frequency in aldosterone-producing cell clusters of normal adrenal gland suggests a requirement for codriver mutations...